Skip to content
Recall Observatory FDA recall evidence

Drug product

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate, Extended-Release Capsules, (Mixed Salts of a Single Entity Amphetamine Product), 15 mg, 100 Capsules, Rx only, Manufactured by: Granules Pharmaceuticals Inc., Chantilly, VA 20151, NDC 70010-031-01

D-0671-2025

August 28, 2025

Class III

Product summary

Firm
Granules Pharmaceuticals Inc.
Event
Event 97504
Status
Ongoing
Classification
Class III
Quantity
9,917 bottles
Official record key
drug-enforcement:D-0671-2025

Official wording

Reason: Failed Impurities/Degradation Specifications:

Code information: Lot#: GPC250178A, Exp Date: 06-22-2027

Distribution pattern: Distributed Nationwide in the USA

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Failed Impurities/Degradation Specifications